Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Chapiro

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|June 8, 2006
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 moleculesTomoko So, Takeshi Hanagiri, Jacques Chapiro, et al.
International Journal of Cancer|January 6, 2011
A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapyWenbin Ma, Nathalie Vigneron, Jacques Chapiro, et al.
Nature Immunology|April 6, 2010
Production of an antigenic peptide by insulin-degrading enzymeNicolas Parmentier, Vincent Stroobant, Didier Colau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2012
Analysis of the processing of seven human tumor antigens by intermediate proteasomesBenoît Guillaume, Vincent Stroobant, Marie-Pierre Bousquet-Dubouch, et al.
Science (New York, N.Y.)|March 6, 2004
An antigenic peptide produced by peptide splicing in the proteasomeNathalie Vigneron, Vincent Stroobant, Jacques Chapiro, et al.
Cancer Research|January 11, 2011
Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastasesVéronique Corbière, Jacques Chapiro, Vincent Stroobant, et al.
Immunological Reviews|November 26, 2002
Tumor-specific shared antigenic peptides recognized by human T cellsPierre Van Der Bruggen, Yi Zhang, Pascal Chaux, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I moleculesBenoît Guillaume, Jacques Chapiro, Vincent Stroobant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentationJacques Chapiro, Stéphane Claverol, Fanny Piette, et al.
The Journal of Experimental Medicine|February 21, 2002
The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasomeErwin S Schultz, Jacques Chapiro, Christophe Lurquin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|June 8, 2006
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 moleculesTomoko So, Takeshi Hanagiri, Jacques Chapiro, et al.
International Journal of Cancer|January 6, 2011
A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapyWenbin Ma, Nathalie Vigneron, Jacques Chapiro, et al.
Nature Immunology|April 6, 2010
Production of an antigenic peptide by insulin-degrading enzymeNicolas Parmentier, Vincent Stroobant, Didier Colau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2012
Analysis of the processing of seven human tumor antigens by intermediate proteasomesBenoît Guillaume, Vincent Stroobant, Marie-Pierre Bousquet-Dubouch, et al.
Science (New York, N.Y.)|March 6, 2004
An antigenic peptide produced by peptide splicing in the proteasomeNathalie Vigneron, Vincent Stroobant, Jacques Chapiro, et al.
Cancer Research|January 11, 2011
Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastasesVéronique Corbière, Jacques Chapiro, Vincent Stroobant, et al.
Immunological Reviews|November 26, 2002
Tumor-specific shared antigenic peptides recognized by human T cellsPierre Van Der Bruggen, Yi Zhang, Pascal Chaux, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I moleculesBenoît Guillaume, Jacques Chapiro, Vincent Stroobant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentationJacques Chapiro, Stéphane Claverol, Fanny Piette, et al.
The Journal of Experimental Medicine|February 21, 2002
The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasomeErwin S Schultz, Jacques Chapiro, Christophe Lurquin, et al.
Pageof 2